Calreticulin Mutations in Myeloproliferative Neoplasms
With the discovery of the JAK2V617F mutation in patients with Philadelphia chromosome-negative (Ph−) myeloproliferative neoplasms (MPNs) in 2005, major advances have been made in the diagnosis of MPNs, in understanding of their pathogenesis involving the JAK/STAT pathway, and finally in the developm...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Rambam Health Care Campus
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222424/ |